Advertisement
IHE or RSPH or XLV
Which ETF would AI Choose? iShares U.S. Pharmaceuticals ETF (IHE) vs. Invesco S&P 500 Equal Weight Health Care ETF (RSPH) vs. Health Care Select Sector SPDR Fund (XLV)
Key Takeaways
- IHE offers concentrated exposure to U.S. pharmaceutical companies through a market-cap-weighted approach with higher expense ratio and fewer holdings.
- RSPH applies equal weighting to healthcare constituents from the S&P 500 Index, providing balanced sector exposure within a rules-based smart-beta framework.
- XLV delivers broad, market-cap-weighted access to the full healthcare sector of the S&P 500 at the lowest cost among the three.
- Structural differences in focus (pharma-only versus full healthcare) and weighting methodology drive distinct diversification and risk profiles.
- Expense ratios range from 0.08% for XLV to 0.40% for RSPH, highlighting notable cost-efficiency variations.
- All three ETFs target the healthcare theme but differ in thematic tilt, with IHE emphasizing pharmaceuticals and the others spanning equipment, providers, and biotech.
Introduction
These three exchange-traded funds (ETFs) provide targeted access to the healthcare sector but pursue distinct strategies. IHE concentrates on U.S. pharmaceuticals, RSPH applies equal weighting to S&P 500 healthcare names, and XLV tracks the broader healthcare sector of the S&P 500 through market-cap weighting. Investors comparing them evaluate differences in sector breadth, concentration risk, cost, and structural construction within the same overarching healthcare theme.
iShares U.S. Pharmaceuticals ETF (IHE) Overview
The iShares U.S. Pharmaceuticals ETF (IHE) seeks to track the Dow Jones U.S. Select Pharmaceuticals Index. It holds approximately 53 securities focused exclusively on U.S. pharmaceutical manufacturers and vaccine producers. Top holdings typically include Eli Lilly and Company (LLY), Johnson & Johnson (JNJ), and several mid-sized peers, resulting in significant concentration. Sector allocation is nearly 100% pharmaceuticals. The fund charges an expense ratio of 0.37% and uses a sampling strategy within a passive, open-ended structure. Rebalancing occurs quarterly, with market-cap weighting subject to caps on individual constituents.
Invesco S&P 500 Equal Weight Health Care ETF (RSPH) Overview
The Invesco S&P 500 Equal Weight Health Care ETF (RSPH) tracks the S&P 500 Equal Weight Health Care Index. It holds roughly 60 securities drawn from S&P 500 healthcare companies, assigning equal weights to each. Holdings span pharmaceuticals, providers, equipment, and biotechnology. Top positions rotate among names such as Moderna, Centene, and others due to the equal-weight methodology. The fund maintains approximately 100% healthcare allocation and carries an expense ratio of 0.40%. It follows a passive, rules-based smart-beta approach with quarterly rebalancing to maintain equal weights.
Health Care Select Sector SPDR Fund (XLV) Overview
The Health Care Select Sector SPDR Fund (XLV) tracks the Health Care Select Sector Index, representing the healthcare component of the S&P 500. It holds about 63 securities across pharmaceuticals, equipment and supplies, providers and services, biotechnology, and life sciences tools. Top holdings commonly feature large-cap names such as Eli Lilly and Company (LLY) and Johnson & Johnson (JNJ). Allocation remains nearly 100% healthcare. XLV applies market-cap weighting within a passive structure and features the lowest expense ratio at 0.08%. Rebalancing aligns with S&P 500 index changes.
Industry and Thematic Landscape
The healthcare sector encompasses pharmaceuticals, medical devices, providers, biotechnology, and related services. Macroeconomic drivers include aging populations, innovation in drug development, regulatory approvals, and shifts in healthcare policy. Capital flows often favor companies with strong pipelines or cost-containment solutions. Geopolitical factors and supply-chain considerations can influence equipment and manufacturing segments, while earnings trends among major pharmaceutical firms affect overall sector sentiment. Sector risks include pricing pressures, patent expirations, and evolving reimbursement environments.
Performance and Positioning Comparison
In recent market cycles, the three ETFs have exhibited varying sensitivity to healthcare-specific catalysts and broader economic conditions. IHE’s pharma concentration can lead to amplified moves tied to individual drug approvals or clinical results. RSPH’s equal-weight approach tends to moderate volatility compared with cap-weighted peers by limiting dominance of the largest names. XLV’s broad, cap-weighted exposure often delivers smoother trend consistency aligned with large-cap healthcare performance. Differences in drawdowns and relative strength arise primarily from concentration levels and weighting methodologies rather than short-term price fluctuations.
AI Screener
Tickeron’s AI Screener is an AI-powered stock and ETF discovery tool that helps traders and investors filter the market based on technical patterns, fundamentals, trends, volatility, and AI-driven signals. Users can scan thousands of stocks and ETFs using customizable filters such as industry, market capitalization, technical indicators, price patterns, and performance metrics. The screener helps identify trade ideas, trending stocks, breakout candidates, and market opportunities more efficiently than manual screening. Explore the AI Screener to refine your ETF research.
Tickeron AI Verdict
Based on observable structural characteristics, Tickeron’s AI would currently assign the highest probability of favorable risk-adjusted positioning to the Health Care Select Sector SPDR Fund (XLV). Its combination of broad diversification across the healthcare sector, market-cap weighting aligned with large-cap stability, and the lowest expense ratio supports efficient exposure with reduced concentration risk relative to the alternatives.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
IHE's Indicator enters downward trend
The Aroon Indicator for IHE entered a downward trend on October 12, 2026. Tickeron's A.I.dvisor identified a pattern where the AroonDown red line was above 70 while the AroonUp green line was below 30 for three straight days. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options. A.I.dvisor looked at 156 similar instances where the Aroon Indicator formed such a pattern. In 132 of the 156 cases the stock moved lower. This puts the odds of a downward move at 85%.
Technical Analysis (Indicators)
Bearish Trend Analysis
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 3 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where IHE declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 77%.
IHE broke above its upper Bollinger Band on October 22, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Bullish Trend Analysis
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where IHE's RSI Indicator exited the oversold zone, 21 of 26 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 81%.
The Momentum Indicator moved above the 0 level on October 15, 2026. You may want to consider a long position or call options on IHE as a result. In 68 of 85 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 80%.
The Moving Average Convergence Divergence (MACD) for IHE just turned positive on October 15, 2026. Looking at past instances where IHE's MACD turned positive, the stock continued to rise in 38 of 52 cases over the following month. The odds of a continued upward trend are 73%.
IHE moved above its 50-day moving average on October 20, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a +3.86% 3-day Advance, the price is estimated to grow further. Considering data from situations where IHE advanced for three days, in 287 of 345 cases, the price rose further within the following month. The odds of a continued upward trend are 83%.
RSPH in +0.99% Uptrend, growing for three consecutive days on October 22, 2026
Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where RSPH advanced for three days, in 252 of 302 cases, the price rose further within the following month. The odds of a continued upward trend are 83%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on October 09, 2026. You may want to consider a long position or call options on RSPH as a result. In 72 of 87 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 83%.
The Moving Average Convergence Divergence (MACD) for RSPH just turned positive on October 12, 2026. Looking at past instances where RSPH's MACD turned positive, the stock continued to rise in 40 of 50 cases over the following month. The odds of a continued upward trend are 80%.
The Aroon Indicator entered an Uptrend today. In 238 of 304 cases where RSPH Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 78%.
Bearish Trend Analysis
The 10-day RSI Indicator for RSPH moved out of overbought territory on October 23, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 30 similar instances where the indicator moved out of overbought territory. In 23 of the 30 cases, the stock moved lower in the following days. This puts the odds of a move lower at 77%.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 9 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where RSPH declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 77%.
RSPH broke above its upper Bollinger Band on October 14, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
XLV in upward trend: 10-day moving average broke above 50-day moving average on October 15, 2026
The 10-day moving average for XLV crossed bullishly above the 50-day moving average on October 15, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 12 of 13 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 90%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on October 14, 2026. You may want to consider a long position or call options on XLV as a result. In 77 of 97 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 79%.
The Moving Average Convergence Divergence (MACD) for XLV just turned positive on October 09, 2026. Looking at past instances where XLV's MACD turned positive, the stock continued to rise in 43 of 48 cases over the following month. The odds of a continued upward trend are 90%.
XLV moved above its 50-day moving average on October 09, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a +4.44% 3-day Advance, the price is estimated to grow further. Considering data from situations where XLV advanced for three days, in 265 of 327 cases, the price rose further within the following month. The odds of a continued upward trend are 81%.
The Aroon Indicator entered an Uptrend today. In 222 of 271 cases where XLV Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 82%.
Bearish Trend Analysis
The 10-day RSI Indicator for XLV moved out of overbought territory on October 23, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 37 similar instances where the indicator moved out of overbought territory. In 30 of the 37 cases, the stock moved lower in the following days. This puts the odds of a move lower at 81%.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 9 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where XLV declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 82%.
XLV broke above its upper Bollinger Band on October 14, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
| IHE | RSPH | XLV | |
|---|---|---|---|
| RSI ODDS (%) | 2 days ago 81% | 2 days ago 77% | 2 days ago 81% |
| Stochastic ODDS (%) | 2 days ago 77% | 2 days ago 78% | 2 days ago 77% |
| Momentum ODDS (%) | 2 days ago 80% | 2 days ago 83% | 2 days ago 79% |
| MACD ODDS (%) | 2 days ago 73% | 2 days ago 80% | 2 days ago 90% |
| TrendWeek ODDS (%) | 2 days ago 82% | 2 days ago 81% | 2 days ago 82% |
| TrendMonth ODDS (%) | 2 days ago 85% | 2 days ago 82% | 2 days ago 84% |
| Advances ODDS (%) | 10 days ago 83% | 3 days ago 83% | 10 days ago 81% |
| Declines ODDS (%) | 6 days ago 77% | 6 days ago 77% | 6 days ago 82% |
| BollingerBands ODDS (%) | 2 days ago 81% | 2 days ago 76% | 2 days ago 80% |
| Aroon ODDS (%) | 2 days ago 85% | 2 days ago 78% | 2 days ago 82% |
Advertisement
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| TSCV | 30.15 | 0.03 | +0.09% |
| Thrivent Small Cap Value ETF (TSCV) | |||
| MYCF | 25.05 | 0.02 | +0.06% |
| State Street My2026 Corporate Bond ETF (MYCF) | |||
| FPE | 16.89 | -0.03 | -0.18% |
| First Trust Preferred Securities & Income ETF (FPE) | |||
| BRNY | 56.06 | -0.31 | -0.55% |
| Burney U.S. Factor Rotation ETF (BRNY) | |||
| HODU | 9.22 | -0.32 | -3.32% |
| Direxion Daily HOOD Bull 2X ETF (HODU) | |||
IHE and
Correlation & Price change
A.I.dvisor indicates that over the last year, IHE has been closely correlated with LLY. These tickers have moved in lockstep 80% of the time. This A.I.-generated data suggests there is a high statistical probability that if IHE jumps, then LLY could also see price increases.
RSPH and
Correlation & Price change
A.I.dvisor indicates that over the last year, RSPH has been closely correlated with BDX. These tickers have moved in lockstep 67% of the time. This A.I.-generated data suggests there is a high statistical probability that if RSPH jumps, then BDX could also see price increases.
| Ticker / NAME | Correlation To RSPH | 1D Price Change % | ||
|---|---|---|---|---|
| RSPH | 100% | -0.80% | ||
| BDX - RSPH | 67% Closely correlated | -0.75% | ||
| SYK - RSPH | 63% Loosely correlated | +0.02% | ||
| STE - RSPH | 62% Loosely correlated | -0.03% | ||
| RMD - RSPH | 61% Loosely correlated | -0.08% | ||
| MDT - RSPH | 61% Loosely correlated | -1.22% | ||
More | ||||
XLV and
Correlation & Price change
A.I.dvisor indicates that over the last year, XLV has been closely correlated with LLY. These tickers have moved in lockstep 73% of the time. This A.I.-generated data suggests there is a high statistical probability that if XLV jumps, then LLY could also see price increases.